MMP13 and breast carcinoma: In addition, studies have also shown that MMP13 is overexpressed in tumors, such as nasopharyngeal carcinoma, cutaneous squamous cell carcinoma, breast cancer, and head and neck squamous cell carcinoma, making it a potential diagnostic and therapeutic target13.